142 related articles for article (PubMed ID: 30710319)
1. A miRNA-HERC4 pathway promotes breast tumorigenesis by inactivating tumor suppressor LATS1.
Xu Y; Ji K; Wu M; Hao B; Yao KT; Xu Y
Protein Cell; 2019 Aug; 10(8):595-605. PubMed ID: 30710319
[TBL] [Abstract][Full Text] [Related]
2. WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells.
Yeung B; Ho KC; Yang X
PLoS One; 2013; 8(4):e61027. PubMed ID: 23573293
[TBL] [Abstract][Full Text] [Related]
3. The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice.
Zhang Z; Tong J; Tang X; Juan J; Cao B; Hurren R; Chen G; Taylor P; Xu X; Shi CX; Du J; Hou J; Wang G; Wu D; Stewart AK; Schimmer AD; Moran MF; Mao X
Blood; 2016 Mar; 127(13):1676-86. PubMed ID: 26825710
[TBL] [Abstract][Full Text] [Related]
4. [Expression of E3 ligase HERC4 in breast cancer and its clinical implications].
Zhou H; Shi R; Chen Y; Zeng W; Liang S; Zheng W; Ma W
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jul; 34(8):1110-4. PubMed ID: 25176076
[TBL] [Abstract][Full Text] [Related]
5. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.
Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM
Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303
[TBL] [Abstract][Full Text] [Related]
6. The miR-1185-2-3p-GOLPH3L pathway promotes glucose metabolism in breast cancer by stabilizing p53-induced SERPINE1.
Xu Y; Chen W; Liang J; Zeng X; Ji K; Zhou J; Liao S; Wu J; Xing K; He Z; Yang Y; Liu Q; Zhu P; Liu Y; Li L; Liu M; Chen W; Huang W
J Exp Clin Cancer Res; 2021 Jan; 40(1):47. PubMed ID: 33509226
[TBL] [Abstract][Full Text] [Related]
7. HERC4 Is Overexpressed in Hepatocellular Carcinoma and Contributes to the Proliferation and Migration of Hepatocellular Carcinoma Cells.
Zheng Y; Li J; Pan C; Zhou G; Zhuge L; Jin L; Fang P
DNA Cell Biol; 2017 Jun; 36(6):490-500. PubMed ID: 28430527
[TBL] [Abstract][Full Text] [Related]
8. HERC4 exerts an anti-tumor role through destabilizing the oncoprotein Smo.
Sun X; Sun B; Cui M; Zhou Z
Biochem Biophys Res Commun; 2019 Jun; 513(4):1013-1018. PubMed ID: 31010679
[TBL] [Abstract][Full Text] [Related]
9. Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected].
Ho KC; Zhou Z; She YM; Chun A; Cyr TD; Yang X
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4870-5. PubMed ID: 21383157
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.
Salah Z; Melino G; Aqeilan RI
Cancer Res; 2011 Mar; 71(5):2010-20. PubMed ID: 21212414
[TBL] [Abstract][Full Text] [Related]
11. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.
Zhao D; Zhi X; Zhou Z; Chen C
Carcinogenesis; 2012 Jan; 33(1):59-67. PubMed ID: 22045023
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells.
Tordjman J; Majumder M; Amiri M; Hasan A; Hess D; Lala PK
BMC Cancer; 2019 Jun; 19(1):561. PubMed ID: 31185986
[TBL] [Abstract][Full Text] [Related]
13. Hippo Stabilises Its Adaptor Salvador by Antagonising the HECT Ubiquitin Ligase Herc4.
Aerne BL; Gailite I; Sims D; Tapon N
PLoS One; 2015; 10(6):e0131113. PubMed ID: 26125558
[TBL] [Abstract][Full Text] [Related]
14. The expression and clinical significance of HERC4 in breast cancer.
Zhou H; Shi R; Wei M; Zheng WL; Zhou JY; Ma WL
Cancer Cell Int; 2013 Nov; 13(1):113. PubMed ID: 24225229
[TBL] [Abstract][Full Text] [Related]
15. WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein.
Zou J; Zhou L; Le Y; Fang Z; Zhong M; Nie F; Wei X; Zhang X; Chen Z; Cai L; Wang H; Xiong J; Fang Z; Xiang X
Cell Commun Signal; 2023 Feb; 21(1):38. PubMed ID: 36803368
[TBL] [Abstract][Full Text] [Related]
16. Acetylation Stabilizes Phosphoglycerate Dehydrogenase by Disrupting the Interaction of E3 Ligase RNF5 to Promote Breast Tumorigenesis.
Wang C; Wan X; Yu T; Huang Z; Shen C; Qi Q; Xiang S; Chen X; Arbely E; Ling ZQ; Liu CY; Yu W
Cell Rep; 2020 Aug; 32(6):108021. PubMed ID: 32783943
[TBL] [Abstract][Full Text] [Related]
17. Increased Expression of MicroRNA 551a by c-Fos Reduces Focal Adhesion Kinase Levels and Blocks Tumorigenesis.
Anuj ; Arivazhagan L; Venkatraman G; Rayala SK
Mol Cell Biol; 2019 Apr; 39(7):. PubMed ID: 30670568
[TBL] [Abstract][Full Text] [Related]
18. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis.
Ren C; Yang T; Qiao P; Wang L; Han X; Lv S; Sun Y; Liu Z; Du Y; Yu Z
Mol Oncol; 2018 May; 12(5):690-704. PubMed ID: 29570932
[TBL] [Abstract][Full Text] [Related]
19. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
Wu H; Li J; Guo E; Luo S; Wang G
Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
[TBL] [Abstract][Full Text] [Related]
20. HERC4 modulates ovarian cancer cell proliferation by regulating SMO-elicited hedgehog signaling.
Zhu Q; Yang X; Lv Y
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130557. PubMed ID: 38181892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
